Nickel is used in industries to make stainless steel and other alloys. This constitutes the primary sources of nickel accounting for approximately 80 % . Electroplating accounts for 10 % usage. Approximately 5 % of primary nickel is used in various foundry applications and printing inks (2) . The distribution and the end uses of nickel are summarized in Figure 1 and Table 1 , respectively. The different forms of nickel include elemental nickel (nickel), nickel oxide (NiO), nickel chloride (NiCl 2 ), nickel sulfate (NiSO 4 ), nickel carbonate (NiCO 3 ), nickel monosulfi de (NiS), and nickel subsulfi de (Ni 3 S 2 ).
For the average person, inhalation accounts for approximately 0.1 -1 µ g nickel daily, excluding tobacco smoke. For workers in nickel industries, inhalation is the primary source of exposure. Total nickel is signifi cantly higher in occupationally exposed individuals than in the general population (5) . Whereas the approximate amount of nickel likely to be inhaled by the general population would range from 0.1 to 0.25 mg nickel/day, in nickel-refi ning operations such as matte handling or grinding, 0.3 -0.8 mg nickel/day has been reported as the average amount of nickel likely to be inhaled. Inhalation amounts can range from < 0.02 to 1.0 mg nickel/day, depending upon the industry. For example, the average airborne nickel concentrations for powder metallurgy operations have been reported to exceed 1.0 mg/m 3 . Grandjean et al. (6) reported that cigarette smoking increases exposure to nickel by 0.0004 mg/day.
Nickel absorption and deposition in the body
Inhalation, dermal contact, and gastrointestinal ingestion are the primary routes of exposure to nickel. The deposition of nickel particles into the nasopharyngeal, pulmonary, or bronchial regions of the respiratory tract is dependent on the particle size. Particles are classifi ed as respirable or irrespirable based on their size. Water insoluble nickel compounds enter cells by phagocytosis and are contained in cytoplasmic vacuoles, which are acidifi ed thus accelerating the dissolution of soluble nickel from the particles (7) . Following exposure (48 -72 h ) of human lung (A549) cells to NiS particles, most of the nickel is contained in the nucleus, whereas cells exposed to soluble NiCl 2 exhibit most of the ions localized in the cytoplasm. According to Vincent (8) , humans inhale particles with aerodynamic diameters < 30 µ m. Particles < 10 µ m are deposited in the lower regions of the lung. Removal of nickel from the respiratory tract occurs via mucociliary transport. Nickel metal is poorly absorbed by the skin, but compounds such as NiCl 2 and NiSO 4 can penetrate occluded skin, resulting in 77 % absorption within 1 day (9) .
Nickel toxicity in humans
Acute toxicity in humans results from inhalation or absorption through the gastrointestinal tract. The mechanisms of nickel toxicity have been recently reviewed by Das and Buchner (10) . Briefl y, the primary route for the toxicity of nickel is though the depletion of glutathione levels and bonding to the sulfhydryl groups of proteins (11) . A study in humans by the United States Environmental Protection Agency (US EPA) (12) revealed that nickel treatment causes irreversible lung damage, abnormal pulmonary functions, renal tubular necrosis, anemia, eosinophilia, and nasal septum ulceration. Alteration of physiological chemistry by reducing nitrogen retention, glucosuria, phosphaturia, and urinary excretion of calcium ion and zinc ion following nickel treatment has also been reported. The inhibition of ATPase activity can lead to neurologic disorders, convulsions, and coma. Chronic exposure resulting in reduced nicotinamide can disrupt oxidative phosphorylation (13) .
Oxidative stress Ni(II) induces oxidative stress in cultured human lymphocytes (14) . When compared with other metal species in one study, nickel is only mildly active in reactive oxygen species (ROS) induction, with the order of increasing toxicity being Ni(II) < Cr(VI) < Cd(II) (15) . Ni(II) alone does not cause effi cient free-radical generation from oxygen, hydrogen peroxide (H 2 O 2 ), or lipid hydroperoxides; nevertheless, the reactivity of Ni(II) with oxygen derivatives can be modulated by chelation with certain histidine-and cysteine-containing ligands. Free-radical generation from the reaction of Ni(II)-thiol complexes with molecular oxygen and/or lipid hydroperoxides could play an important role in the mechanism(s) of Ni(II) toxicity [reviewed in detail in (10) ].
Hematoxicity A study in mice by Dieter et al. (16) demonstrated that the primary toxic effects of nickel sulfate occur in the myeloid system, expressed as a doserelated decrease in bone marrow cellularity, as well as in granulocyte-macrophage and pluripotent stem cell proliferative responses. In the US, National Toxicology Program (NTP) inhalation studies in F344/N rats and B6C3F1 mice (17) , the increases in hematocrit (PCV % ), hemoglobin concentration, and erythrocyte counts were consistent with the production of erythropoietin in response to tissue hypoxia. Other studies have reported different results [reviewed in (10) ].
Immunotoxicity An allergic skin reaction is the most common effect in people with sensitivity to nickel [reviewed in (18) ]. Nickel is capable of evoking a dual response in the human immune system, with both immunomodulatory and immunotoxic effects, sometimes in the same individual. Human studies on the potential immunotoxicity of nickel are limited. Inhalation exposure is a primary route for nickelinduced immunotoxicity in the workplace. Skin allergies, lung fi brosis, and respiratory tract cancer are some of the conditions/diseases related to exposure to highly nickelpolluted environments. Research has shown a correlation between nickel-induced facial dermatitis and cell phone use (19 -22) . Thyssen and Maibach (23) tested inexpensive jewelry for various nickel concentrations. Hair clamps, earrings, and necklaces for women showed nickel concentrations of 19.3 % , 14.8 % , and 12.9 % respectively, which can lead to cutaneous skin allergies. Analysis of hair clamps and fi nger rings for children indicated nickel levels of 79.4 % and 20 % , respectively (24) . Children ' s clothing fasteners were also identifi ed as a source of excessive nickel concentrations leading to cutaneous skin allergies (25) .
Nickel-induced carcinogenicity
The ability of nickel compounds to raise the intracellular concentration of nickel ions established the basis for its carcinogenic potential. Human and animal studies have demonstrated that exposure to nickel refi nery dusts and Ni 3 S 2 increases the probability of lung and nasal cancer in workers. Nickel refi nery dust and Ni 3 S 2 are classifi ed as human carcinogens (Group A) by the US EPA and Group 1 by the International Agency for Research on Cancer (26) , as well as the US Department of Health and Human Services (US DHHS) (27) . An increased incidence of cancers occurred in mice following nickel administration via inhalation or injection. The US EPA classifi es nickel carbonyl as a probable human carcinogen (Group B2) based on the incidences of pulmonary carcinomas and malignant tumors in rats after exposure by inhalation and intravenous injection (28) . Chronic inhalation to nickel has been linked to chronic bronchitis and several cancers (3) . Current evidence shows a close relationship between nickel exposure and increased lung cancer risk in nickel refi neries (29 -31) . The primary areas commonly researched include investigations of nickel species-specifi c effects, as well as possible dose-response relationships between nickel exposure and lung cancer. Assessments have been usually based on the measurement of nickel concentration in lung tissue to estimate the exposure level.
A general feature of metallic compounds is their property to enhance the mutagenicity and carcinogenicity of directly acting genotoxic agents. The characterization of this property is based on their ability to inhibit the repair of damaged DNA. The induction of DNA damage has been linked to the ability of nickel to bind to DNA and nuclear proteins (32) . Nickel also interferes with nucleotide and base-excision repair at low, non-cytotoxic concentrations. Both soluble and insoluble forms of nickel impair the repair of DNA adducts caused by benzo[a]pyrene (33) . Other evidence supports the theory that carcinogenic metal compounds change gene expression motifs, contributing to stimulated cell proliferation, either by activation of proto-oncogenes or interfering with tumorsuppressor genes responsible for downregulating cell growth (34) .
The suppressive effect of nickel on natural killer cell activity and interferon production on the involvement of nickel carcinogenesis has been at the forefront of several immunologic studies (35, 36) . The ability of nickel to cause chromosomal damage both in vitro and in vivo is in agreement with its mutagenic characteristics.
The carcinogenic potential of nickel is directly proportional to the ability of metal to enter cells and increase intracellular levels of nickel ions. A relationship between respiratory carcinogenic potential and the bioavailability of nickel ion at nuclear sites within respiratory target cells has been reported (37) , helping to reconcile the human, animal, and mechanistic data for soluble nickel compounds. Water-soluble nickel compounds by themselves are not considered complete human carcinogens because of the predicted lack of bioavailability of nickel ion at target sites. By contrast, the inhalation of concentrations high enough to induce chronic lung infl ammation augments the carcinogenic risks associated with inhalation exposure to other substances.
Both NiS and Ni 3 S 2 are water-insoluble forms of nickel that enter cells by phagocytosis and potently increase the likelihood of tumor formation in vitro. Water-insoluble nickel compounds are more potent forms of carcinogens compared with the soluble forms (37) . A dye that fl uoresces when bound to intracellular nickel ions was used to track the fate of both forms of nickel in a time-dependent study (38) . The results showed that within 10 h after removal of NiCl 2 from the culture medium, the nickel ions disappeared from the nucleus and by 16 h were no longer detected in the cells, whereas following nickel removal, insoluble Ni 3 S 2 yielded nickel ions that persisted in the nucleus after 16 h and could still be detected in the cytoplasm even after 24 h.
Between 1902 and 1923, the International Nickel Company (INCO) operating a nickel refi nery in Clydach, Wales, UK, reported a total of 365 respiratory cancers, including 85 nasal and 280 lung cancers, among their workers (26) . As a result of the suggestion that arsenic might be the carcinogenic agent responsible for the high incidence of respiratory cancer, orcelite, a nickel arsenide, was eliminated from the refi nery process in 1924. Subsequent to the reduction of nickel arsenide in the recycling process, between 1925 and 1930 the incidences of nasal and respiratory cancers greatly decreased (39 (40) . Their fi ndings correlated with the increased incidence of respiratory tract carcinogenicity found in the workers before the removal of orcelite from the refi nery process, suggesting that orcelite plays a crucial role in the induction of nasal and lung cancers. The 1929 dust sample did not produce any morphologic change in the cultured cells.
In addition to the primary routes of exposure, another nickel source emerged in Nigeria. Nduka and Orisakwe (41) sampled various pediatric cough suppressants for the presence of heavy metals. Of the metals tested, nickel was present in two brands (Magcid and Gaviron) of oral suspensions at concentrations of 4.13 mg/L and 0.79 mg/L, respectively. Based on these fi ndings, the authors recommended that precautions should be taken when using these suspensions because of a signifi cant source of heavy metal exposure in children. In addition to caution, the pediatric syrups should be considered a public health problem (41) .
Clinical studies Epidemiologic studies have confi rmed a signifi cant increase in nasal and lung carcinogenesis during exposure to nickel compounds, especially in workers in the nickel industry (30, 31, 42) . Respiratory carcinogenicity assessment of soluble nickel compounds has provided evidence of lung and nasal cancers among exposed subjects. For a Norwegian nickel refi nery, Grimsrud et al. (42) studied time-and department-specifi c exposure to nickel, arsenic, sulfuric acid mists, and cobalt, as well as asbestos, to determine whether lung cancer risk was related only to nickel. Length of time and duration of work were the experimental variables. The results suggested a correlation between total exposure to water-soluble nickel and lung cancer risk. To support Grimsrud et al. ' s fi ndings, other researchers reported similar results related to exposure to nickel compounds. In Harjavalta, Finland, 1155 workers were exposed to nickel for 25 years in the smelter, repair shop, and refi nery (30) . Workers in the refi nery, who were exposed primarily to NiSO 4 at levels below 0.5 mg/m 3 , as well as to low concentrations of other nickel compounds, showed increased risk for nasal cancer [standardized incidence ratio (SIR) 41.1, 95 % confi dence interval (CI) 4.97 -148], positively associated with latency and duration of employment, and an excess risk for lung cancer (SIR 2.61, 95 % CI 0.96 -5.67). This study provided evidence that elevated nasal and lung cancer can result from primary exposure to NiSO 4 .
Kiilunen et al. (31) performed nickel analysis in air, blood, and urine on workers in a nickel refi nery industry with an increased number of nasal cancers. Acridine orange-stained smears of micronuclei from the buccal mucosa of workers were used to study genotoxic effects. Respirators used in high-exposure areas in 1966 -1988 yielded a nickel concentration of 0.9 -2.4 µ g/m 3 . Nickel concentrations in the breathing zone were 1.3 µ g/m 3 , and airborne nickel concentrations (stationary sampling) varied between 230 and 800 µ g/m 3 , with no systematic change. Follow-up tests revealed lower concentrations of 170 -460 µ g/m 3 . After shift, the urinary concentrations of nickel were 0.1 -2 µ mol/L, showing no correlation with nickel concentrations in air. Following a 2 -4 week vacation, the concentrations of nickel in the urine were still elevated.
Animal studies According to the NTP, Ni 3 S 2 , NiO, and NiSO 4 hexahydrate are linked to cancer in animals (43) . The NTP conducted a 2-year study on male and female mice following inhalation exposure to NiO for 16 days, 13 weeks, or 2 years. In addition, in mice exposed to NiO for 13 weeks, genetic toxicology tests were conducted in peripheral blood. In the 16 days study, groups of fi ve male and fi ve female mice were exposed for 12 exposure days to NiO, ranging from 0 to 30 mg NiO/m 3 , for 6 h/day, 5 days/week. Mice exposed to nickel > 10 mg/m 3 had a signifi cant increase in absolute and relative lung weight compared with the control group. Pigment particles were present in the lungs of mice exposed to ≥ 2.5 mg/m 3 . In both genders exposed to 10 and 30 mg/m 3 , an accumulation of macrophages in alveolar spaces was observed. The concentrations of NiO in the lungs of all exposed groups of mice were signifi cantly greater than those in the lungs of control animals (males, 32 -84 mg Ni/g 1 lung; females, 31 -71 mg Ni/g lung). The 13-week study involved 10 male and 10 female rats exposed to 0, 0.6, 1.2, 2.5, 5, and 10 mg NiO/m 3 for 5 days/week, 6 h/day. In this study, the researchers observed chemical-related non-neoplastic lesions in the lungs of both genders following exposure to concentrations of 2.5 mg/m 3 or higher, which were generally more severe with increased exposure concentration. In addition, an accumulation of alveolar macrophages and lymphoid hyperplasia pigmentation of the bronchial and mediastinal lymph nodes were observed in mice exposed to 2.5, 5, or 10 mg/m 3 . In males exposed to 0.6, 2.5, or 10 mg/m 3 , the concentration of NiO in the lungs was greater than that in the lungs of controls at 4, 9, and 13 weeks and continued to accumulate in the lung at the end of the 13-week exposures.
During the 2-year study, 65 male and 65 female mice were exposed to different concentrations of NiO (0, 0.62, 1.25, and 2.5 mg NiO/m 3 ) over a 104-week study period, exposed for 5 days/week and 6 h/day. At 2 years, pathology fi ndings showed that the incidence of alveolar/bronchiolar adenoma in the 2.5 mg/m 3 females was signifi cantly greater than that of the controls, as was the incidence of alveolar/bronchiolar adenoma or carcinoma (combined) in 1.25 mg/m 3 females. At 7 and 15 months, the chronic lung infl ammation increased with exposure concentration. In groups exposed to ≥ 0.62 mg/m 3 , alveolar and bronchial pigmentation was observed 7 months following exposure. At the conclusion of the 2-year study, bronchialization, proteinosis, infl ammation, and pigmentation in the lung and lymphoid hyperplasia and pigmentation in the bronchial lymph nodes were observed in mice following exposure to NiO (43) .
Overall, the NTP study found some evidence of carcinogenic activity of NiO in male F344/N rats based on the increased incidences of alveolar/bronchiolar adenoma or carcinoma (combined) and increased incidences of benign or malignant pheochromocytoma (combined) of the adrenal medulla. Some evidence of carcinogenic activity of NiO was found in female F344/N rats based on the increased incidences of alveolar/bronchiolar adenoma or carcinoma (combined) and increased incidences of benign pheochromocytoma of the adrenal medulla. No evidence of carcinogenic activity of NiO was found in male B6C3F1 mice exposed to 1.25, 2.5, or 5 mg/m 3 . In female B6C3F1 mice, equivocal evidence of carcinogenic activity of NiO was observed, based on marginally increased incidences of alveolar/bronchiolar adenoma in 2.5 mg/m 3 females and of alveolar/bronchiolar adenoma or carcinoma (combined) in 1.25 mg/m 3 females. The exposure of rats to NiO for 2 years resulted in infl ammation and pigmentation in the lung, lymphoid hyperplasia, and pigmentation in the bronchial lymph nodes, and hyperplasia of the adrenal medulla (females). The exposure of mice to NiO for 2 years resulted in bronchialization, proteinosis, infl ammation, and pigmentation in the lung and lymphoid hyperplasia and pigmentation in the bronchial lymph nodes.
Nickel subsulfi de (Ni 3 S 2 ) is used in the production of lithium batteries and is found in the nickel ore refi nery industry. Exposure to Ni 3 S 2 through inhalation contributes to lung cancer. The NTP studied mice and rats exposed by inhalation to 97 % pure Ni 3 S 2 for 6 h/day, 5 days/week for different periods of time (16 days, 13 weeks, or 2 years). The concentrations of Ni 3 S 2 administered were 0, 0.6, 1.2, 2.5, 5, and 10 mg/m 3 . The exposed animals showed increased infl ammation of lung and atrophy of the nasal olfactory epithelium (44) . The authors concluded that under the conditions of these 2-year inhalation studies, clear evidence emerged of carcinogenic activity of Ni 3 S 2 in male and female F344/N rats. No evidence of carcinogenic activity of Ni 3 S 2 was found in male or female B6C3F1 mice exposed to 0.6 or 1.2 mg/m 3 . The fi ndings suggest that both Ni 3 S 2 and NiO and compounds reach the nucleus in larger quantities than do water-soluble nickel compounds such as NiSO 4 (45) . Studies by Heim et al. (46) support the theory that nickel inhalation is the primary route of exposure relevant to carcinogenic hazards and risks.
Nickel-induced genotoxicity
In this section, we discuss genetic and epigenetic studies that have been conducted to unravel the exact mechanisms of nickel-induced carcinogenesis. Experimental studies have shown that nickel disrupts DNA strands, DNA crosslinks, and DNA repair. Oxidative stress has been found to play a key role in nickel-induced carcinogenicity (47, 48) . The production of ROS is facilitated by the ability of nickel to bind with amino acids, peptides, and proteins. A common fi ber in all known cancers is the acquisition of abnormalities in the genetic material of the cancer cell. Cell hypoxia is believed to signifi cantly affect the development of cancer and other cellular regulatory switches. Several studies have shown that both soluble and insoluble nickel compounds can cause human lung and nasal cancers. Insoluble nickel compounds are phagocytized in acidic cytoplasmic vacuoles that expedite the dissolution of soluble nickel from the particles.
Oxidative stress and DNA damage Several studies suggest that oxidative stress could be important in nickelinduced carcinogenesis [reviewed in (48) ]. Mutation and cell proliferation are the end products of the multistep process of chemical carcinogenesis. Oxidative stress can occur as a result of the overproduction of reactive oxygen and nitrogen species via endogenous and exogenous insults. A modifi cation of gene expression and mutation caused by the upregulation and extended production of cellular oxidants are crucial in the study of carcinogenesis (47) . The formation of ROS can be attributed to various events and pathways. The hydroxyl radical reacts with all components of the DNA molecule. Oxidative damage occurring as a result of permanent modifi cation of genetic material represents the conception stage of mutagenesis, carcinogenesis, and aging. As a result of DNA damage, the arrest or induction of transcription, induction of signal transduction pathways, replication errors, and genomic instability all contribute to carcinogenesis. Metal-induced generation of oxygen radicals result in an attack on DNA in the cell nucleus, in addition to other cellular components involving polyunsaturated fatty acid residues of phospholipids that are extremely sensitive to oxidation (48) .
In HL-60 human leukemia cells, long-term exposure to Ni 2 + ions led to DNA fragmentation, cell death, and ROS. By contrast, the prevention of Ni Oxidative DNA damage is one of the most important mechanisms associated with an array of terminal diseases including cancer. DNA damage can be initiated through radiation and chemical oxidation in addition to other methods not fully understood. Kelly et al. (51) used high performance liquid chromatography with ultra-violet spectroscopy and electro-chemical detection (HPLC-UV-EC) to provide evidence of the oxidation of DNA mediated by Ni(II) through an oscillatory formation of 8-oxoguanine from free guanine and from guanine in DNA. The formation of oxidized-guanidinohydantoin from free guanine at pH 11 and the formation of guanidinohydantoin from DNA at pH 5.5 were observed using a high performance liquid chromatography with mass spectrometry and/mass spectrometry detection (HPLC-MS/ MS) method. Researchers tested different metals at concentrations ranging from 0.5 to 5.0 mM to assess DNA damage, apoptosis, necrosis, and proliferation responses of a human T-helper lymphocyte (Jurkat) cell line after exposure (52) . In addition to vanadium, nickel was the only metal to induce DNA damage at nearly the same concentrations that induced > 50 % apoptosis (i.e., < 0.05 mM). Another study by Wu et al. (53) investigated the effects of nickel-refi ning dusts in mouse NIH/3T3 cells. DNA damage was determined using the single cell gel electrophoresis technique. The percentage of tail DNA increased with increasing doses of nickel-refi ning dusts under the same condition of the same treatment time. After 4 h of exposure, DNA strand breaks reached the peak value in comparison with 2-h and 24-h exposure times.
Genotoxic stress assists in the mobilization of transposons, which are the source of genome instability. One example of a genotoxic effect is a double-stranded DNA break that threatens the integrity of the genome, activates cell cycle checkpoints, and, in some cases, causes cell death. In the modern day human genome, L1 retrotransposons are the most active autonomous mobile elements (54) . Nickel chloride has been shown to stimulate L1 retrotransposition approximately 2.5-fold. Stimulation of the L1 transposons occurs at the post-transcriptional level, probably during the integration process. Determination of the exact mechanism of the L1 stimulation is limited owing to the highly complex nature of the effect of nickel on the cell. The stimulation results from a decrease in DNA repair activities that infl uence the downstream events of retrotransposition. These fi ndings provide a novel mechanism that must be considered when dealing with genomic damage/instability in response to environmental agents (55) .
Testicular DNA damage Epidemiologic studies suggest that certain paternal exposures to metals can increase the likelihood of cancer in progeny. Such routes include exposure to metal dusts and fumes, including welding fumes. Nickel is one of the primary suspects capable of producing promutagenic damage to sperm DNA. Protamines are found tightly packed in sperm DNA, which can isolate and sequester carcinogenic transition metals and modulate oxidative damage. Studies have shown that human protamine P2 has a NI(II) -and Cu(II) -binding amino acid pattern at its N-terminus, Arg-Thr-His-, which attracts metals. Liang et al. (56) found that Ni(II) and Cu(II) bound to pentadecapeptide modeling [Arg-Thr-HisGly-Glnn-Ser-His-Tyr-Arg-Arg-Arg-His-Cys-Ser-Argamide] were able to mediate oxidative DNA double-strand scission and generation of 8-oxo-2 ′ -deoxyguanosine from free 2 ′ deoxyguanosine and from DNA by H 2 O 2 . The data suggest that Ni(II) could be mechanistically involved in the reproductive toxicity and carcinogenicity of metals. Li and Wang (57) reported that exposure of male mice to Ni 2 + chloride resulted in a transient amount of Ni 2 + in testes accompanied by a reduced sperm count and chromosomal aberrations. In addition to the aforementioned change, Ni 2 + treatment slightly increased Cu + 2 levels in the testes. DNA damage by ROS, including base alteration, crosslinking, strand cleaving (58) , and/or depurination, generated in Ni 2 + -and Cu 2 + -mediated redox reactions with the participation of endogenous oxidants (59) are possible causes of these aberrations [discussed in (56) ].
Molecular and cellular interactions Cell surface receptors
Recent studies have shown that nickel compounds are capable of interacting with cell surface receptors, such as the widely distributed extracellular Ca 2 + -sensing receptor (CaSR) that can be activated by divalent cations. Cortijo et al. (60) reported that nickel triggers intracellular Ca 2 + mobilization in human airway epithelial cells through the activation of CaSR, which translates into pathophysiological outputs potentially related to pulmonary disease. The interaction between nickel and cell surface receptors activates cell signaling, which induces the calcium and hypoxia-inducible factor pathway, as described in (17) . After hypoxia-inducible factors have been induced, cells have the potential to survive in an anaerobic environment, thereby enabling the previously initiated cancer cells to advance into a full malignant state and metastasize (61) . The nucleotide excision repair pathway is affected by watersoluble and particulate nickel compounds (62) .
Nickel compounds have been found to raise the intracellular concentration of nickel ions, thereby establishing a basis for carcinogenic potential. According to Costa et al. (61) , nickel-induced carcinogenesis is related to the molecular and cellular events related to the compound. Nickel compounds enter the nucleus and interact with chromatin to induce carcinogenic activity. Heterochromatinization has recently been proposed as a potential mechanism of nickel-induced carcinogenesis (63) .
Hypoxia-inducible signaling pathway
The results of several studies have indicated that nickel exposure is responsible for a hypoxic cellular environment by depletion of iron from the cell (64, 65) . Hypoxia signaling is one pathway that contributes to metal ion-induced carcinogenesis by disrupting cellular iron homeostasis though competition with iron transporters or iron-regulated enzymes. In vitro studies of human and rodent cells by Salnikow et al. (17) showed that the hypoxia-inducible factor (HIF-1) signaling pathway is activated by exposure to carcinogenic nickel compounds. Following acute exposure to nickel, an accumulation of HIF-1 strongly activated hypoxia-inducible genes, including the recently discovered tumor marker NDRG1 (Cap43) (17) . Mice embryos were exposed to NiCl 2 to identify HIF-1-dependent nickel inducible genes and to understand the function of the HIF-1-dependent signaling pathway related to nickel-induced transformation. Nickel induced genes coding for glycolytic enzymes and glucose transporters, which are regulated by HIF-1 transcription factor, only in HIF-1 α -profi cient cells. In addition, several other hypoxia-inducible genes were upregulated by nickel in a HIF-1-dependent manner. Additionally, other genes were induced by nickel in a HIF-1-independent manner, suggesting that nickel exposure activates several signaling pathways. Assessing the induction of these pathways after exposure is essential to the understanding of cancer development related to nickel exposure (17) . The results of a further study by Salnikow et al. (66) indicated that nickel sulfate can induce hypoxia-inducible genes and interleukin 8 production in human lung cells with or without interference with iron metabolism. Subsequent studies by Li et al. (67) revealed the mechanism for a signifi cant stabilization and elevation of HIF-1a protein, which involves a loss of cellular iron, as well as an inhibition of HIF-1a-dependent prolyl hydroxylases that target the binding of VHL ubiquitin ligase and degrade HIF-1a.
8-Hydroxyguanosine formation
Further research by Kawanishi et al. (68) helped to clarify the mechanism of nickel carcinogenesis. In cultured HeLa cells, Ni 3 S 2 induced a signifi cant increase in 8-hydroxydeoxyguanosine (8-OH-dG) formation, whereas NiO, NiO, and NiSO 4 did not. By contrast, the intratracheal instillation of all these nickel compounds in rats signifi cantly increased 8-OH-dG content in the lungs. The authors concluded that two different mechanisms, direct and indirect, for nickel-induced oxidative DNA damage could account for the disparities in DNA damage between cultured cells and animals. In direct oxidative DNA damage, supported by oxidative damage to isolated DNA treated with Ni(II) and H 2 O 2 , Ni(II) enters the cells and then reacts with endogenous and/or NiS-produced H 2 O 2 to give ROS that cause DNA damage, whereas indirect oxidative DNA damage results from infl ammation. A double mechanism for DNA damage could explain the relatively high carcinogenic risk associated with Ni 3 S 2 . In another study, NiSO 4 was shown to signifi cantly increase the level of testicular lipid peroxide and decrease all antioxidant enzymes activities and glutathione levels in Wister strain male albino rats (69) .
Epigenetic mechanisms
Recent evidence has shown that the onset of cancer is preceded by both genetic and epigenetic abnormalities. Epigenetics refers to heritable patterns of gene expression that do not depend on alterations of the genomic DNA sequence. Because nickel compounds have shown carcinogenicity in the absence of mutagenesis, the mechanism of carcinogenesis must be partly epigenetic in nature. Epigenetics involves genomic reprogramming in cancer cells, such as DNA methylation, chemical modifi cation of the histone proteins, and RNA-dependent regulation (70) . Many studies have shown that nickel induces epigenetic silencing or reactivation of gene expression by the induction of DNA methylation (7, 17, 61, 69, 71, 72) , which in turn induces a loss of histone H4 and H3 acetylation and DNA hypermethylation (73) . As a result of gene silencing, the cell is altered to a higher state of neoplastic transformation.
Histones, the major proteins found in chromatin, are responsible for shortening the length of DNA. Histone alterations have been linked to the deregulated expression of many genes that play crucial roles in cancer development and progression. Qingdong et al. (74) provided evidence that nickel induces the phosphorylation of histones at the serine10 residue in a c-jun N-terminal kinase (JNK)/stress-activated protein kinase-dependent manner. Nickel induced the phosphorylation of JNK, with no effect on the phosphorylation states of the extracellular signal-regulated kinase (ERK) or p38 mitogen-activated protein kinases. The evidence was based on a complete loss of nickel ion-induced phosphorylation of H3S10 when JNK was specifi cally knocked down with RNAi.
The intracellular generation of Ni 2 + ion is primarily responsible for the carcinogenicity of specifi c insoluble nickel compounds. For example, the inhibition of Ni 2 + on histone acetylation plays an important role in the suppression or silencing of genes. Ni 2 + inhibits the acetylation of histone H4 through binding with its N-terminal histidine 18. Additionally, Ni 2 + readily produces ROS in vivo, which is an inversely related crucial factor with the occurrence of resistance of mammalian cells to Ni 2 + . Kang et al. (75) reported that a high concentration of Ni 2 + (no less than 600 µ M) caused a cogent decrease of histone acetylation in human hepatoma cells. The result of the inhibition was primarily due to the infl uence of Ni 2 + on overall histone acetyltransferase activity. Simultaneously, the exposure of hepatoma cells to Ni 2 + -generated ROS. Two antioxidants, 2-mercaptoethanol at 2 mM or NAC at 1 mM, with Ni 2 + together completely suppressed the ROS generation and signifi cantly reduced the induced histone hyperacetylation, confi rming that ROS generation plays a role in the inhibition of histone acetylation. This model can serve as a template for Ni 2 + -induced gene suppression and carcinogenesis. Nickel has also been shown to inhibit dioxygenases by impairing epigenetic processes leading to cancer development (76) .
Chromosomal aberrations
Chemical and genetic synergism yields two types of DNA alterations: fi rst, molecular changes in genes, and second chromosomal aberrations secondary to breaks in linear coherence of chromosomes. The segregation of chromosomes through the interaction with the spindle fi ber mechanism is another type of genetic mutation caused by chemicals. This alteration creates non-disjunction and a deviant number of chromosomes. Induced chromosome aberrations produce changes that functionally altered the cell function leaving it capable of proliferation. The results of chromosome aberrations include cell death or at least an inability to complete mitosis (77) . Mammalian cell studies by Nishimura and Umeda (78) indicate that certain nickel compounds, NiCl 2 and Ni(CH 3 COO) 2 , produce chromosomal aberrations (78) . Nickel sulfate has been found to produce genetic and chromosomal alterations in V79 Chinese hamster cells (79) .
Tumor suppressor gene (p53) alteration
One of the fi rst phenotypic changes in the multistage and multifactorial process of carcinogenesis is cellular immortality. Some of these changes activate proto-oncogenes whereas others functionally inactivate tumor suppressor genes. p53 has been tagged a tumor suppressor gene by various studies. Normal cell proliferation and neoplastic transformation is attributed to the nuclear p53. Mutated p53 is commonly found in human cancers. This mutated p53 is usually joined to a 17p deletion in tumors. Studies of normal rodent cells with p53 mutation have revealed cell immortalization, cooperation with transfected ras oncogene, and predisposition to neoplastic transformation. Researchers have found that nickel induces immortalization and point mutation in the conserved region of the p53 gene in human kidney epithelial cells. Prokaryotic systems and mammalian cell mutagenicity assays provide evidence of mutagenic nickel compounds. Cohort studies by M ae hle et al. (80) and Chiocca et al. (81) showed that nickel induces a duplication of the region containing MuSVts 110 3 ′ splice site, suggesting the ability of nickel to act as a mutagen in mammalian cells. A more detailed determination of genetic changes during the stepwise progression of neoplastic transformation after nickel treatment is presently being investigated. Future studies will determine the p53 mutation spectra in Ni(II)-associated renal and lung human cancer in comparison with a spectra with those found in renal and lung cancers occurring in the general population (80) .
Costa et al. (61) suggested that exposure to nickel compounds activates various transcription factors related to the corresponding signal transduction pathways that are associated with nickel carcinogenesis. Using GeneChip analysis to compare gene alterations caused by both soluble and insoluble nickel compounds, Salnikow et al. (82) 
Ect2 proto-oncogene amplifi cation
In an effort to understand the mechanisms of nickel ioninduced cell transformation and the development of biomarkers of nickel ion exposure and nickel-ion-induced cell transformation, Clemens et al. (84) isolated mRNA from green NiO-, crystalline NiS-, and 3-methylcholanthrene (MCA)-transformed C3H/10T1/2 Cl 8 mouse fi broblast cell lines. A mRNA differential display revealed that nine mRNA fragments were differentially expressed between nickel-transformed and non-transformed 10T1/2 cell lines. The expression of fragment R2-5 was observed at higher steady-state levels in transformed cell lines. The R2-5 fragment showed 100 % sequence identity to part of the coding region of Ect2, a mouse proto-oncogene encoding a guanosine diphosphate-guanosine triphosphate (GDP-GTP) exchange factor. The 3.9-kb Ect2 transcript was expressed at 1.6-to 3.6-fold higher steady-state levels in four Ni-transformed and in two MCA-transformed cell lines. In both cell lines, the metal also increased the expression of the Ect2 protein to a 3.0-to 4.5-fold higher steady-state level. The Ect2 gene was amplifi ed by 3.5-to 10-fold in Ni-transformed, and by 2.5-to 3-fold in MCA transformed cell lines. The gene amplifi cation was probably caused by the binding of nickel ions to enzymes of DNA synthesis. The authors concluded that the microtubule disassembly and cytokinesis resulting from Ect2 gene amplifi cation and overexpression of Ect2 mRNA and protein contributed to the induction and maintenance of morphological, anchorage-independent, and neoplastic transformation of both cell lines (84) .
c-Myc transcription factor
The complex nature of cancer formation can also be attributed to the deregulation in various steps of translational control. The c-Myc protein is a transcription factor that is associated with the control of cellular proliferation and differentiation. The protein binds DNA at specifi c sites and determines which genes should be transcribed into mRNA to make additional or other new proteins. Among the numerous biological activities of the c-myc gene are transformation, immortalization, blockage of cell differentiation, and induction of apoptosis. Furthermore, c-Myc is required but not absolutely essential for effi cient progression through the cell cycle [reviewed in (85 -87) ].
The involvement of the oncogene c-myc in the genesis of neoplasia is well documented for several systems. The c-Myc protein controls 15 % of human genes. Both c-Myc mRNA and protein are generally expressed at low levels in normal proliferating cells but are frequently overexpressed in cancer cells. The c-Myc transcription factor also plays a crucial role in the control of translation (88) . Myc has a direct impact on increasing protein synthesis rates by controlling the expression of multiple components of the protein synthetic machinery, including ribosomal proteins and initiation factors of translation, Pol III, and rDNA. Studies have indicated that c-Myc oncogenic signaling has the ability to dominate the translational machinery by eliciting cooperative effects on cell growth, cell cycle progression, and genomic instability leading to the initiation of cancer (88) . Gordan et al. (89) demonstrated that HIF-2 α enhances c-Myc transcriptional activity, thereby promoting hypoxic cell proliferation. Li et al. (90) investigated the effect of nickel on c-myc levels. The results demonstrated that nickel, hypoxia, and other hypoxia mimetics degraded c-Myc protein in several cancer cells and this degradation was dependent upon both HIF-1 α and HIF-2 α . The study also disclosed evidence of two potential pathways mediated nickel induced c-Myc protein degradation: (i) through the phosphorylation of c-myc at T58 by signifi cantly increasing cells exposed to nickel, or (ii) hypoxia, leading to increased ubiquitination through Fbw7 ubiquitin ligase, and the other through a decrease in the c-myc deubi quitinating enzyme, USP28, following nickel and hypoxia exposure. Phosphorylation of c-myc at T58 significantly increased in cells exposed to either nickel or hypoxia, leading to increased ubiquitination through Fbw7 ubiquitin ligase. In addition, nickel or hypoxia exposure decreased USP28, a c-Myc deubiquitinating enzyme, contributing to a higher steady-state level of c-Myc ubiquitination and promoting c-Myc degradation. These mechanisms are important factors in enhanced c-myc ubiquitination and proteasomal degradation (89) .
Another study found that c-Myc protein expression was increased by nickel ions in non-tumorigenic human bronchial epithelial cells (Beas-2B) and keratinocyte HaCaT cells. Further studies in the Beas-2B cells revealed that nickel ion increased the c-Myc mRNA level and c-Myc promoter activity, but did not increase c-Myc mRNA and protein stability. The results demonstrated that c-Myc induction by nickel ions occurs via the Ras/Raf ERK-dependent signaling pathway (91) , which plays a crucial role in nickel-induced apoptosis in human bronchial epithelial cells (92) .
Embryotoxicity
Nickel can cross the human placenta, producing teratogenesis and embryotoxic effects. Chen and Lin (93) conducted a time course experiment on human term placentas incubated with 2.5 mM nickel. Permeability, lipid peroxidation, and nickel concentration were signifi cantly increased compared with the controls, indicating nickel toxicity due to lipid peroxidative damage to the placental membrane. The result of this metabolic change could be responsible for decreased placental viability, altered permeability, and potential subsequent embryotoxicity. Research also suggests that the prenatal effects of nickel could be due to the production of certain mutations in the mitotic apparatus provoking cellular death at crucial times of fetal development (94) .
Conclusions
Nickel, an element that occurs naturally in the earth ' s crust, is found in soils, sediments, water resources, air, plants, and animals. Large amounts of nickel are released into the environment as a result of natural phenomena such as volcanic eruptions or from industrial activities such as nickel mining, nickel alloy production and use, power plants, and incinerators operations. Human exposure to nickel occurs via inhalation of dust particles, ingestion of contaminated food and water, and dermal contact with nickel-containing materials or soil. Although the allergic reaction to nickel is the most common adverse health effect in humans, nickel exposure has also been associated with lung cancer, especially in workers of nickel refi neries and processing plants.
Experimental studies have shown that nickel-induced carcinogenicity involves multiple molecular mechanisms. The proposed mechanisms discussed here suggest the following chain of events -nickel compounds enter the cell, activate the receptor CaSR, triggering intracellular Ca 2 + mobilization, and the induction of the calcium and hypoxia-inducible factor pathways. Nickel enters the nucleus, directly binds to DNA, and reacts with H 2 O 2 to form reactive nickel-oxygen complexes, resulting in the oxidation of thymine and cytosine residues accompanied by 8-OH-dG formation. The oxidative stress generated severely damages DNA and inhibits DNA repair pathways. Nickel compounds can induce indirect damage through infl ammation by stimulating polymorphonuclear leukocytes to produce ROS. Nickel also damages heterochromatin, thereby silencing the expression of genes located near heterochromatin, which in turn induces an epigenetic loss of histone H4 and H3 acetylation and DNA hyper methylation (94) . As a result of gene silencing, the cell is more susceptible to neoplastic transformation. In addition, nickel downregulates the tumor suppressor gene p53, activates the proto-oncogene c-Myc, and induces the activator protein 1 transcription factor, resulting in cellular proliferation and cancer development.
